Veterinary Medicine Information website

Nobilis Rismavac

Authorised
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
Download as PDF

Product identification

Medicine name:
Nobilis Rismavac
Active substance:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
Target species:
  • Chicken
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
    3.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Concentrate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
  • Intramuscular use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 188a/84
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 12/07/2024
Download